Srdjan Markovic

6PUBLICATIONS
20CO-AUTHORS
PharmacogenomicsCardiovascular medicine and haematology not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 26, 2026
Prioritizing Antidiabetic Drugs for Inflammatory Bowel Disease Through Inverse Signal Detection: A FAERS Pharmacovigilance Study.

|Mar 28, 2026
Arterial Thrombosis in Severe Ulcerative Colitis: A Case-Based Narrative Review of Current Evidence.

Djordje Kralj, Mladen Maksic, Tamara Knezevic Ivanovski

|Jan 28, 2026
Pharmacogenomic Pathways Underlying Variable Vedolizumab Response in Crohn's Disease Patients: A Rare-Variant Analysis.

Biljana Stankovic, Mihajlo Stasuk, Vladimir Gasic

|Aug 28, 2025
Real-World Safety of Vedolizumab in Inflammatory Bowel Disease: A Retrospective Cohort Study Supported by FAERS Signal Analysis.

Bojana Milašinović, Sandra Vezmar Kovačević, Srđan Marković

|Aug 28, 2025
Is Deep Remission the Right Time to De-Escalate Biologic Therapy in IBD? A Single-Center Retrospective Study.

Tamara Knezevic Ivanovski, Marija Milic Perovic, Bojan Stopic

|Mar 11, 2021
The Effect of COVID-19 Resurgence on Morbidity and Mortality in Patients With IBD on Biologic Therapy.

Srdjan Markovic, Tamara Knezevic Ivanovski, Branimir Zogovic

Pageof 1

Frequent Collaborators

3 joint publications

Đorđe Kralj

2 joint publications

Sandra Vezmar Kovačević

2 joint publications

Petar Svorcan

2 joint publications

Branislava Miljković